1. Home
  2. VVOS vs ENVB Comparison

VVOS vs ENVB Comparison

Compare VVOS & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.43

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$1.40

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
ENVB
Founded
2016
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
8.1M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
VVOS
ENVB
Price
$0.43
$1.40
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
487.8K
132.7K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
N/A
N/A
Revenue
$17,443,000.00
$39,914,675.00
Revenue This Year
$69.66
N/A
Revenue Next Year
$48.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.38
$0.56
52 Week High
$7.40
$13.25

Technical Indicators

Market Signals
Indicator
VVOS
ENVB
Relative Strength Index (RSI) 37.87 36.40
Support Level $0.38 $0.60
Resistance Level $0.55 $1.58
Average True Range (ATR) 0.06 0.12
MACD 0.01 0.05
Stochastic Oscillator 31.76 35.19

Price Performance

Historical Comparison
VVOS
ENVB

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: